Bryologyx

0 followers

‌

BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies.

Industries

Commercial, Biotechnology

Headquarters

Danville, United States

Employees

1-10

Links

Org chart

Thomas M. Loarie

Co-Founder, CEO & Director

Thomas M. Loarie

Collapse

Reza Ilkhani

CFO

Bruce Jenett

General Counsel

David Crockford

VP, Clinical Development & Logistics

Paola Grandi

Senior Scientist, Immunology

Teams

Advisory Team

9 members

Directors Team

6 members

Leadership Team

5 members

Similar companies

Thermo Fisher Scientific

170 followers

Genentech

156 followers

Gilead Sciences

130 followers

Biogen

117 followers

Illumina

69 followers

Vertex Pharmaceuticals

60 followers

Agilent Technologies

66 followers

Roivant Sciences

56 followers

Alexion Pharmaceuticals

34 followers

bluebird bio

38 followers

Staples

24 followers

Explore companies